Almac Moves to New UK Headquarters, Includes Clinical Services Business Unit
Almac has opened a new £3m building at its Craigavon, UK headquarters from which staff will provide services to customers in over 100 countries around the world.
Around 150 staff who work for Almac’s Clinical Services Business Unit have also moved to the new 30,000 sq ft building to consolidate its services.
Staff working in the pharmaceutical development company’s new offices will co-ordinate and manage the processes involved in global packaging and distribution of medicinal supplies for clinical studies.
Many of the staff are clinical Project Managers and Project Co-ordinators, managing studies on behalf of world-leading pharmaceutical and biotechnology companies. Business Development, Marketing, Human Resources and Information Systems departments are also based in the new building.
Celine Bradley, Global VP of Operations said: “This addition to Almac’s continuously expanding headquarters brings together staff who have been working from different facilities on site for the past few years.
“Almac’s project staff manage clinical studies all around the world, providing cutting edge services that enhance the global clinical supply chain and contribute to the ethical goal of getting new treatments into the market faster
“Investment in our staff, state of the art global facilities and ongoing delivery of innovative services positions Almac as the premium provider of clinical trial supply chain solutions.”
Carrying out the clinical studies requires specific manufacture, packaging and labelling to prepare bespoke packs for distribution around the world. The company is constantly reviewing how to keep the drugs safe using its unique systems to monitor temperature conditions during transit and cut wastage. Over 90% of Almac’s sales come from outside the UK and its global supply network now extends into 32 countries and 37 depots.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
